UCSF Innovation Ventures logo
UCSF Catalyst Awards

UCSF Catalyst Awards

Supports UCSF investigators with seed funding that starts healthcare innovation and accelerates patient-facing pilots.

Opens 2026UCSF Innovation VenturesUnited StatesDeep-tech · core fit

⚠ This may reflect a past cycle — verify the current call on the funder's site.

UCSF Innovation Ventures operates the Catalyst Program as UCSF's primary translational accelerator, designed to move UCSF discoveries with clinical impact and commercial potential along the path from academic research to patient benefit. Since 2010, the Catalyst Program has distributed $13 million across 313 awards — approximately 21 awards per year — and the portfolio has generated $751 million in total follow-on funding since inception, including $595 million in startup equity. The Catalyst Award is the program's flagship mechanism and is offered exclusively in the fall annual cycle.

Each Catalyst Award provides up to $75,000 in seed funding alongside structured industry advisor mentorship delivered through a three-stage review process: an initial committee screening, a consultation phase with industry advisors, and a final report-out presentation session. Eligible applicants are UCSF faculty in any series (Ladder Rank, In Residence, Clinical X, Health Science Clinical, or Adjunct) at any rank from Instructor upward. Students, residents, postdoctoral fellows, and specialists may serve as PI if a faculty member serves as Co-PI. IP must be assigned to or jointly owned by the Regents of the University of California. The award funds therapeutics (lead optimization, IND-enabling studies), diagnostics (biomarker validation), medical devices (prototyping, bench and animal testing), and digital or computational health (AI, LLMs, clinical workflow integration); discovery research is explicitly excluded. Faculty salary is not allowable; publication fees are capped at $5,000.

The FY2025–2026 cycle closed September 29, 2025, with final awardees selected in April 2026. The Fall 2026 cycle deadline is expected circa late September 2026 based on the program's consistent annual cadence; the official RFP will be posted at rapapp.ucsf.edu. Applications require a single PDF (maximum 3 pages excluding bios, citations, and budget) submitted through the RAP portal. Proposals are scored on unmet medical need, scientific rationale, development feasibility, commercial attractiveness, and IP status.

Translational validation of therapeutics, diagnostics, medical devices, and digital or computational health technologies with a clear path to clinical implementation or commercialization; discovery research is not funded.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.28 weeks
Project durationiHow long the funded work is expected to run.12 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Last verified: 23 Jun 2026Source: rap.ucsf.edu